Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2007

01-09-2007 | Original Paper

CRP Correlates with Clinical Score in Ulcerative Colitis but Not in Crohn’s Disease

Authors: Alexander D. Rodgers, Adrian G. Cummins

Published in: Digestive Diseases and Sciences | Issue 9/2007

Login to get access

Abstract

The aim of this study was to prospectively evaluate the correlation between clinical scoring systems and C-reactive protein (CRP) in inflammatory bowel disease. The modified Harvey-Bradshaw index was used in 40 patients (58 assessments) with Crohn’s disease, and the Lichtiger score in 29 patients (36 assessments) with ulcerative colitis. In ulcerative colitis, CRP was elevated in 14%, 42%, 64%, and 83%, respectively, of subjects with quiescent, mild, moderate, and severe disease. There was a linear correlation of log(CRP) with clinical score except for proctitis. In Crohn’s disease, CRP was elevated in 54%, 70%, 75%, and 100%, respectively, of subjects with quiescent, mild, moderate, and severe disease. We conclude that the clinical score has a good correlation with CRP in ulcerative colitis except for proctitis, whereas clinical score has a poor correlation with CRP in Crohn’s disease, particularly in those with clinically quiescent, fibrostenotic, and ileal disease.
Literature
1.
go back to reference Camilleri M, Proana M (1989) Advances in the assessment of disease activity in inflammatory bowel disease. Mayo Clin Proc 64:800–807PubMed Camilleri M, Proana M (1989) Advances in the assessment of disease activity in inflammatory bowel disease. Mayo Clin Proc 64:800–807PubMed
2.
go back to reference Gomes P, du Boulay C, Smith CL, Holdstock G (1986) Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 27:92–95PubMed Gomes P, du Boulay C, Smith CL, Holdstock G (1986) Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 27:92–95PubMed
3.
go back to reference Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJF, Chadwick VS (1986) Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease: a comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology 90:1121–1128PubMed Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJF, Chadwick VS (1986) Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease: a comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology 90:1121–1128PubMed
4.
go back to reference Papi C, Ciaco A, Bianchi M, Montani S, Koch M, Capurso L (1996) Correlation of various Crohn’s disease activity indexes in subgroups of patients with primarily inflammatory or fibrostenosing clinical characteristics. J Clin Gastroenterol 23:40–43PubMedCrossRef Papi C, Ciaco A, Bianchi M, Montani S, Koch M, Capurso L (1996) Correlation of various Crohn’s disease activity indexes in subgroups of patients with primarily inflammatory or fibrostenosing clinical characteristics. J Clin Gastroenterol 23:40–43PubMedCrossRef
5.
go back to reference Sachar DB, Smith H, Chan S, Cohen LB, Lichtiger S, Messer J (1986) Erythrocyte sedimentation rate as a measure of clinical activity in inflammatory bowel disease. J Clin Gastroenterol 8:647–650PubMedCrossRef Sachar DB, Smith H, Chan S, Cohen LB, Lichtiger S, Messer J (1986) Erythrocyte sedimentation rate as a measure of clinical activity in inflammatory bowel disease. J Clin Gastroenterol 8:647–650PubMedCrossRef
6.
go back to reference Prantera C, Davoli M, Lorenzetti R, Pallone F, Marcheggiano A, Iannoni C, Mariotti S (1988) Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most. J Clin Gastroenterol 10:41–45PubMedCrossRef Prantera C, Davoli M, Lorenzetti R, Pallone F, Marcheggiano A, Iannoni C, Mariotti S (1988) Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most. J Clin Gastroenterol 10:41–45PubMedCrossRef
7.
go back to reference Fagan EA, Dyck RF, Maton PN, Hodgson HJF, Chadwick VS, Petrie A, Pepys MB (1989) Serum levels of C-reactive peptide in Crohn’s disease and ulcerative colitis. Eur J Clin Invest 12:351–359CrossRef Fagan EA, Dyck RF, Maton PN, Hodgson HJF, Chadwick VS, Petrie A, Pepys MB (1989) Serum levels of C-reactive peptide in Crohn’s disease and ulcerative colitis. Eur J Clin Invest 12:351–359CrossRef
8.
go back to reference Sachar DB, Luppescu NE, Bodian C, Shlien RD, Fabry TL, Gumaste VV (1990) Erythrocyte sedimentation as a measure of Crohn’s disease activity: opposite trends in ileitis versus colitis. J Clin Gastroenterol 12:643–646PubMedCrossRef Sachar DB, Luppescu NE, Bodian C, Shlien RD, Fabry TL, Gumaste VV (1990) Erythrocyte sedimentation as a measure of Crohn’s disease activity: opposite trends in ileitis versus colitis. J Clin Gastroenterol 12:643–646PubMedCrossRef
9.
go back to reference Best WR, Becktel JM, Singleton JW, Kern Jr F (1976) Development of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study. Gastroenterology 70:439–444PubMed Best WR, Becktel JM, Singleton JW, Kern Jr F (1976) Development of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study. Gastroenterology 70:439–444PubMed
10.
go back to reference Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841–1845PubMedCrossRef Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841–1845PubMedCrossRef
11.
12.
go back to reference Talstad I, Gjone E (1976) The disease activity of ulcerative colitis and Crohn’s disease. Scand J Gastroenterol 11:403–408PubMed Talstad I, Gjone E (1976) The disease activity of ulcerative colitis and Crohn’s disease. Scand J Gastroenterol 11:403–408PubMed
13.
go back to reference Dearing WH, McGuckin WH, Elveback LR (1986) Serum alpha 1-acid glycoprotein in chronic ulcerative colitis. Gastroenterology 56:295–303 Dearing WH, McGuckin WH, Elveback LR (1986) Serum alpha 1-acid glycoprotein in chronic ulcerative colitis. Gastroenterology 56:295–303
14.
go back to reference Cooke WT, Prior P (1984) Determining disease activity in inflammatory bowel disease. J Clin Gastroenterol 6:17–25PubMed Cooke WT, Prior P (1984) Determining disease activity in inflammatory bowel disease. J Clin Gastroenterol 6:17–25PubMed
15.
go back to reference Talstasd I, Gjone E (1976) The disease activity of ulcerative colitis and Crohn’s disease. Scand J Gastroenterol 11:403–408 Talstasd I, Gjone E (1976) The disease activity of ulcerative colitis and Crohn’s disease. Scand J Gastroenterol 11:403–408
16.
go back to reference Florin TH, Paterson EW, Fowler EV, Radford-Smith GL (2006) Clinically active Crohn’s disease in the presence of a low C-reactive protein. Scand J Gastroenterol 41:306–311PubMedCrossRef Florin TH, Paterson EW, Fowler EV, Radford-Smith GL (2006) Clinically active Crohn’s disease in the presence of a low C-reactive protein. Scand J Gastroenterol 41:306–311PubMedCrossRef
17.
go back to reference Savermyuttu SH, Hodgson HJF, Chadwick VS, Pepys MB (1986) Differing acute phase responses in Crohn’s disease and ulcerative colitis. Gut 27:809–813 Savermyuttu SH, Hodgson HJF, Chadwick VS, Pepys MB (1986) Differing acute phase responses in Crohn’s disease and ulcerative colitis. Gut 27:809–813
18.
go back to reference Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: Useful magic, or unnecessary toys? Gut 55:426–432PubMedCrossRef Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: Useful magic, or unnecessary toys? Gut 55:426–432PubMedCrossRef
19.
go back to reference Chamouard P, Richert Z, Meyer N, Rahmi G, Bauman R (2006) Diagnostic value of C-reactive protein for predicting activity level of Crohn’s disease. Clin Gastroenterol Hepatol 4:882–887PubMedCrossRef Chamouard P, Richert Z, Meyer N, Rahmi G, Bauman R (2006) Diagnostic value of C-reactive protein for predicting activity level of Crohn’s disease. Clin Gastroenterol Hepatol 4:882–887PubMedCrossRef
Metadata
Title
CRP Correlates with Clinical Score in Ulcerative Colitis but Not in Crohn’s Disease
Authors
Alexander D. Rodgers
Adrian G. Cummins
Publication date
01-09-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9691-2

Other articles of this Issue 9/2007

Digestive Diseases and Sciences 9/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.